Brain amyloid and cognition in Lewy body diseases. - Wikidata - wikimedia - TriplyDB

Brain amyloid and cognition in Lewy body diseases.

Brain amyloid and cognition in Lewy body diseases.

http://www.wikidata.org/entity/Q37050071

about

11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Brain PET in the diagnosis of Alzheimer's disease Beta-amyloid deposition in chronic traumatic encephalopathy Biomarkers for dementia and mild cognitive impairment in Parkinson's disease.Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia The spectrum of cognitive impairment in Lewy body diseases Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study Positive florbetapir PET amyloid imaging in a subject with frequent cortical neuritic plaques and frontotemporal lobar degeneration with TDP43-positive inclusions.Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an (11)C altropane positron emission tomography study.Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review.Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease Can we clinically diagnose dementia with Lewy bodies yet?PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies Meta-analysis of amyloid-cognition relations in cognitively normal older adults Amyloid-Beta Positron Emission Tomography Imaging of Alzheimer's Pathology in Parkinson's Disease Dementia.Increased phosphorylation of collapsin response mediator protein-2 at Thr514 correlates with β-amyloid burden and synaptic deficits in Lewy body dementias Amyloid imaging in atypical presentations of Alzheimer's disease.Decision-Making Deficits Associated with Amyloidosis in Lewy Body Disorders.Neurobiology of cognitive impairment in Parkinson's disease.Dementia with Lewy bodies: early diagnostic challenges.PET approaches for diagnosis of dementia.What can biomarkers tell us about cognition in Parkinson's disease?Imaging the role of amyloid in PD dementia and dementia with Lewy bodies.Biomarkers in biological fluids for dementia with Lewy bodies.Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.Imaging Amyloidopathy in Parkinson Disease and Parkinsonian Dementia Syndromes.Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis.An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias Review: The spectrum of clinical features seen with alpha synuclein pathology.Lewy Body Disorders.Predicting Regional Pattern of Longitudinal β-Amyloid Accumulation by Baseline PET.Multimodal PET Imaging of Amyloid and Tau Pathology in Alzheimer Disease and Non-Alzheimer Disease Dementias.Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.Paired Studies Comparing Clinical Profiles of Lewy Body Dementia with Alzheimer's and Parkinson's Diseases.Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort.Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies Reply: Beyond the limits of detection: failure of PiB imaging to capture true Aβ burden.Amyloid PET imaging: applications beyond Alzheimer's disease.

P2860

Q24194742-E24BCEDB-64E6-4B85-BA8D-DC41F1C1C002 Q27011549-F9BBA04D-4629-4258-AEDE-E61FEBAE5811 Q28385330-E6BB9BE2-85D0-4960-9A5E-0BF6AB64C0A7 Q31097119-44F8B167-5F14-476D-A5BD-BE1A381C8B66 Q33727909-789A32D1-22EB-4ACD-81FF-B7DE7A0BF77F Q34019751-88578BC2-C008-42C8-ACA1-286F8AD3A162 Q34174901-C0F9E4B6-EE2D-40D4-AFA2-2168A45A673A Q34207044-8470A35E-72A3-42D1-93FF-7BFF409C5728 Q34554452-CA3A2C96-F650-4EB9-B4ED-A25DA8F7067D Q34576144-455723A6-1E65-4F41-95D2-0894E0BAEE23 Q34714560-CB9BCFC7-40DA-4E6C-81BC-85F9299F8F46 Q35603195-7596E48E-3A27-4DE1-BD49-B46F7F696CB5 Q36494215-3B8700F7-30AD-4B5A-9E8C-1E49A510DBA3 Q36618103-97791D6A-D252-4E50-82A8-92657793F111 Q36817876-360761EB-4E77-4673-AFDC-3C5C77502A70 Q36850873-0E4026F4-9405-4B22-B00A-0C14D64C9E3F Q37148091-A319C6F0-69F1-42D9-A79F-61D67503CB00 Q37243713-58CA559E-7705-4286-B70F-C41EB6791C34 Q37393266-D93B2E55-935C-4A84-9997-B573DBA7802B Q37578245-8689BD1A-0C2E-43EA-AD88-1AFF26E64B6F Q38067143-0FB1FAB5-57A5-48B7-B584-C2EDD81301AF Q38126115-BBC1449B-73D8-4E3F-89AE-27CB45DBC532 Q38128957-1EBDEC30-5EA7-4E8E-97AC-735A8650C2BB Q38206497-D2C71C4F-4A4B-453F-8049-04763595D087 Q38228098-102F2A03-2457-4C0F-BFF7-1B7E8CB81F1B Q38283550-AAAA0579-0E5B-4B0E-AE5B-9FFD29349D57 Q38311234-ADCCF82A-5711-4499-A913-7AA56B1B9A5A Q38368611-58CCDE31-6DF2-498B-997E-427F302EB8B7 Q38600277-120C4017-D94F-410D-A76B-7D232A71219D Q38628562-12357366-CE14-437C-8ED2-E5D91FA93890 Q38691823-8BE7FAEB-4928-45B1-A0B5-5B8FAF2CE105 Q39243369-066CEB93-F5D5-4866-87CA-FD1CE05AD772 Q39277051-5DFC1730-BBFD-441A-A8E5-64AE00B261F8 Q39346750-F2C51488-6AB6-4BF6-9161-E1650B86E24D Q39365272-61FF8AE5-6D41-466B-8DA6-BD48E2AF437A Q39447026-ED1CDBE0-5BCB-4DC4-B472-CF1B32075FCF Q40604774-F3D700A3-0162-49DC-A02C-419E55ABB95A Q41635671-2FD8F607-EC16-41A5-8335-25B6F92D3226 Q42551830-2E0D7F3F-5F88-4E6C-B2DC-10F45B8D0C67 Q43161462-D12E29E4-8571-46F7-BA35-54758AB50A36

P2860

Brain amyloid and cognition in Lewy body diseases.

http://www.wikidata.org/entity/Q37050071

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 June 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Brain amyloid and cognition in Lewy body diseases.

@en

Brain amyloid and cognition in Lewy body diseases.

@nl

type

label

Brain amyloid and cognition in Lewy body diseases.

@en

Brain amyloid and cognition in Lewy body diseases.

@nl

prefLabel

Brain amyloid and cognition in Lewy body diseases.

@en

Brain amyloid and cognition in Lewy body diseases.

@nl

P1433

Q37050071-DAEB6D60-8BC9-4089-AB0A-4B7FCE2C1F74

P1476

Q37050071-05385E56-5557-410C-896E-1E62E902BF5B

P2093

Q37050071-0DEC56A5-558C-433D-8EB3-36A569202B1E

Q37050071-12471375-FD58-4FB1-BB56-824B5CDB42D6

Q37050071-4FF67C4B-9193-4A95-91E9-D5B71B53955E

Q37050071-7F52AA2B-9773-4F33-AE6A-DF945430EBC2

Q37050071-99C488B6-1358-463B-AC01-D6250CEF89E7

Q37050071-EC736AF8-8425-4C0B-8149-DF354FBCD2E7

Q37050071-F0C5BBD8-3EAD-4281-B274-0FE2FD78A871

P2860

Q37050071-0A11EFCB-48A3-4A78-9DF8-7F74F2F945C2

Q37050071-0EF82AAE-45FF-4348-B372-021C5EEEE172

Q37050071-20CDB47F-3798-411C-AD87-1B1190318545

Q37050071-2363AFC8-7518-4A14-B489-1120B07372C1

Q37050071-243279B2-B6F5-4EBA-B5FE-26EC971F7FCD

Q37050071-2CE9BBCF-F305-4BCA-9D4E-FC381D8E4A3C

Q37050071-3026EC0A-80FB-4CFC-8154-09CA46FB41E1

Q37050071-3453FA3A-7A8D-4653-898B-8AF7F2FED09E

Q37050071-3A45B277-91CE-4727-AD38-57004D4D4940

Q37050071-4151802E-85E7-4188-B9C2-A5F9A30D2E2B

P304

Q37050071-34167048-A855-4597-A7DC-C2A7125A781D

P31

Q37050071-7C7C5602-E80B-4459-9E59-696714060443

P356

Q37050071-B9CBE868-DA27-4D2E-90BB-BDA30250CA14

P407

Q37050071-8F7EB2B2-8880-4DE0-BEA6-3FB38FAAA4B2

P433

Q37050071-30D41507-23AD-4615-B7BC-6FE6C7B2CC19

P478

Q37050071-080AD6DB-C01E-4B03-A1ED-E4C2B5D5636A

P50

Q37050071-F008092C-155A-4686-9BE1-78BF2AE4EB22

P577

Q37050071-AAA04808-E8E7-494D-8DB5-9C29BBD164C0

P698

Q37050071-C39231CE-9ADB-4006-BC64-FD25EEAB044C

P932

Q37050071-262A758E-FAF0-4EE5-9E72-331E4D886964

P356

P1433

Movement Disorders

P1476

Brain amyloid and cognition in Lewy body diseases.

@en

P2093

Andrea L Santarlasci

http://www.w3.org/2001/XMLSchema#string

Dorene M Rentz

http://www.w3.org/2001/XMLSchema#string

Jacqueline Maye

http://www.w3.org/2001/XMLSchema#string

John H Growdon

http://www.w3.org/2001/XMLSchema#string

Joseph J Locascio

http://www.w3.org/2001/XMLSchema#string

Keith A Johnson

http://www.w3.org/2001/XMLSchema#string

Stephen N Gomperts

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Statistical parametric maps in functional imaging: A general linear approach

Staging of brain pathology related to sporadic Parkinson's disease

Parkinsonism: onset, progression and mortality

APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

The Clinical Dementia Rating (CDR): current version and scoring rules

Amyloid and glucose imaging in dementia with Lewy bodies and multiple systems atrophy.

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

P304

965-973

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.25048

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22693110

http://www.w3.org/2001/XMLSchema#string

P932

3725259

http://www.w3.org/2001/XMLSchema#string